Free Trial

CVS Health (CVS) Stock Price, News & Analysis

CVS Health logo
$63.42 -1.68 (-2.57%)
Closing price 02/21/2025 03:59 PM Eastern
Extended Trading
$63.43 +0.02 (+0.02%)
As of 02/21/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About CVS Health Stock (NYSE:CVS)

Key Stats

Today's Range
$62.02
$65.29
50-Day Range
$43.78
$66.35
52-Week Range
$43.56
$80.75
Volume
14.12 million shs
Average Volume
11.80 million shs
Market Capitalization
$79.95 billion
P/E Ratio
17.33
Dividend Yield
4.19%
Price Target
$70.00
Consensus Rating
Moderate Buy

Company Overview

CVS Health Corporation, founded in 1963 by Stanley Goldstein, Sidney Goldstein and Ralph Hoagland, began as Melville, a health and beauty aid store chain in Lowell, Massachusetts. 

In 1996, CVS Corporation spun off from Melville and became a standalone company trading as CVS on the New York Stock Exchange. Today, CVS Health Corporation is a leading American healthcare company that owns CVS Pharmacy, CVS Caremark and Aetna.

CVS Health Corp offers its customers a range of health solutions. It operates through three main segments: healthcare benefits, pharmacy services and retail. The Health Care Benefits segment provides various traditional, voluntary and consumer-directed health insurance products to different groups, including individuals, employer groups, college students, health care providers and governmental units. 

The pharmacy services segment offers a range of pharmacy benefit management solutions, including plan design and administration, clinical, formulary management, retail pharmacy network management, specialty pharmacy and infusion and medical spend management services. This segment serves insurance companies, prescription drug plans, health plans, unions, employers, Medicaid-managed care plans and individuals. 

The retail segment sells prescription and over-the-counter drugs, personal care products and consumer health and beauty products. It also provides health care services through MinuteClinic walk-in medical clinics. It distributes prescription drugs while offering pharmacy consulting and other ancillary services to care facilities and different care settings. Additionally, it operates specialty mail-order, retail specialty pharmacy stores, compounding pharmacies and branches for infusion and enteral nutrition services.

CVS Health Corporation is one of the largest healthcare providers in the United States. In 2021, it ranked fourth on the Fortune 500 list and seventh on the Fortune Global 500 list. 

The company faced criticism in November 2021 when a federal jury found that CVS, Walgreens and Walmart "had substantially contributed to" the opioid crisis. Despite this setback, CVS Health Corp remains dedicated to its broader healthcare commitment, as reflected by its decision to change its corporate name to CVS Health in September 2014. In February 2020, CVS Health announced changes to its board of directors, reducing the size from 16 to 13 directors.

In December 2017, CVS Health Corp agreed to acquire Aetna for $69 billion, completing the acquisition in November 2018. The purchase of Aetna, a leading health insurance company, allowed CVS Health Corp to expand its services to a broader range of customers. 

CVS Health Corp's success is also due to its subsidiary, Caremark, established in 1979 by James M. Sweeney as Home Health Care of America (HHCA), which later changed its name to Caremark in 1985. In 1996, Caremark merged with MedPartners/Mullikin Inc., the combined company called MedPartners Inc. In 1998, MedPartners changed its name to Caremark Rx. Caremark was fined $160 million in 1991 for a "four-year-long federal mail-fraud and kickback" scheme in which it "paid doctors to steer patients to its intravenous drug service."

On November 18, 2021, CVS Health announced plans to close 900 stores over the next three years, with closing beginning in the spring of 2022. The company's decision to close stores could result from increased competition in the healthcare industry, changing consumer behavior and the COVID-19 pandemic. The company is confident in its ability to continue to provide quality healthcare services to customers.

CVS Health Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
100th Percentile Overall Score

CVS MarketRank™: 

CVS Health scored higher than 100% of companies evaluated by MarketBeat, and ranked 7th out of 954 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    CVS Health has received a consensus rating of Moderate Buy. The company's average rating score is 2.90, and is based on 17 buy ratings, 3 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    CVS Health has been the subject of 14 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about CVS Health's stock forecast and price target.
  • Earnings Growth

    Earnings for CVS Health are expected to grow by 14.94% in the coming year, from $5.89 to $6.77 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of CVS Health is 17.33, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 23.65.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of CVS Health is 17.33, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 26.79.

  • Price to Earnings Growth Ratio

    CVS Health has a PEG Ratio of 0.98. PEG Ratios around 1 indicate that a company is correctly valued.

  • Price to Book Value per Share Ratio

    CVS Health has a P/B Ratio of 1.06. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about CVS Health's valuation and earnings.
  • Percentage of Shares Shorted

    1.71% of the float of CVS Health has been sold short.
  • Short Interest Ratio / Days to Cover

    CVS Health has a short interest ratio ("days to cover") of 1.6, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in CVS Health has recently increased by 25.66%, indicating that investor sentiment is decreasing significantly.
  • Dividend Leadership

    CVS Health is a leading dividend payer. It pays a dividend yield of 4.09%, putting its dividend yield in the top 25% of dividend-paying stocks.

  • Dividend Growth

    CVS Health does not have a long track record of dividend growth.

  • Dividend Coverage

    The dividend payout ratio of CVS Health is 72.68%. This payout ratio is at a healthy, sustainable level, below 75%.

  • Dividend Sustainability

    Based on earnings estimates, CVS Health will have a dividend payout ratio of 39.29% next year. This indicates that CVS Health will be able to sustain or increase its dividend.

  • Read more about CVS Health's dividend.
  • Percentage of Shares Shorted

    1.71% of the float of CVS Health has been sold short.
  • Short Interest Ratio / Days to Cover

    CVS Health has a short interest ratio ("days to cover") of 1.6, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in CVS Health has recently increased by 25.66%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    CVS Health has a news sentiment score of 1.11. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.60 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 75 news articles for CVS Health this week, compared to 33 articles on an average week.
  • Search Interest

    132 people have searched for CVS on MarketBeat in the last 30 days. This is an increase of 2% compared to the previous 30 days.
  • MarketBeat Follows

    Only 51 people have added CVS Health to their MarketBeat watchlist in the last 30 days. This is a decrease of -23% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, CVS Health insiders have bought more of their company's stock than they have sold. Specifically, they have bought $2,001,000.00 in company stock and sold $0.00 in company stock.

  • Percentage Held by Insiders

    Only 0.24% of the stock of CVS Health is held by insiders.

  • Percentage Held by Institutions

    80.66% of the stock of CVS Health is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about CVS Health's insider trading history.
Receive CVS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for CVS Health and its competitors with MarketBeat's FREE daily newsletter.

CVS Stock News Headlines

Top view of doctor
Humana Gains Despite Medicare Advantage Losses—What’s the Catch? (CVS)
Humana is the second largest health insurance provider of Medicare Advantage (MA) plans sounding the alarms of rising medical costs but will now cut 10%
West Bangal, India - October 09, 2021 : CVS Health logo on phone screen stock image. — Stock Editorial Photography
CVS Health: Earnings Beat Ignites Stock Rally
CVS Health's stock is showing upward movement after exceeding quarterly earnings expectations, suggesting a potential positive shift.
$5,000 DOGE check?
Elon Musk's DOGE agenda just took a very surprising turn... Earlier this week, reports emerged that a portion of the savings DOGE makes in Federal cuts could be funneled back to taxpayers. The media was quick to dub it a DOGE Dividend, with claims circulating that we could all receive a $5,000 check in the mail.
CVS pharmacy and drive-thru signs are seen outside of CVS store in Park Ridge, Ill
CVS Health steers through rising insurance costs in a strong fourth quarter
CVS Health’s adjusted fourth-quarter profit handily beat Wall Street’s estimates, even as the drugstore chain and pharmacy benefits manager dealt with rising costs in its insurance division
Cigna Close-up of a tablet pc with a digital screen. — Photo by Wirestock
Cigna Misses EPS: What It Means for the Health Insurance Industry (CVS)
Cigna is one of the most efficiently managed health insurance companies evidenced by its foresight to sell its Medicare Advantage business before the fallout.
CVS cuts bonuses after low profit levels in 2024
See More Headlines

CVS Stock Analysis - Frequently Asked Questions

CVS Health's stock was trading at $44.89 at the beginning of the year. Since then, CVS shares have increased by 41.3% and is now trading at $63.4150.
View the best growth stocks for 2025 here
.

CVS Health Co. (NYSE:CVS) posted its quarterly earnings results on Wednesday, February, 12th. The pharmacy operator reported $1.19 earnings per share for the quarter, topping analysts' consensus estimates of $0.89 by $0.30. CVS Health had a trailing twelve-month return on equity of 9.11% and a net margin of 1.24%.
Read the conference call transcript
.

The following companies are subsidiaries of CVS Health: IlliniCare Health, EntrustRX, Aetna, TargetPharmacy, Omnicare, Navarro Discount Pharmacy, Coram Specialty Infusion, and more.

CVS Health's top institutional shareholders include Vanguard Group Inc. (9.33%), Dodge & Cox (5.57%), Capital World Investors (4.85%) and FMR LLC (2.24%). Insiders that own company stock include Thomas M Moriarty, Karen S Lynch, Alan Lotvin, Prem S Shah, Michael F Mahoney, Edward J Ludwig, James David Clark and Daniel P Finke.
View institutional ownership trends
.

Shares of CVS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that CVS Health investors own include NVIDIA (NVDA), Meta Platforms (META), Symbotic (SYM), JPMorgan Nasdaq Equity Premium Income ETF (JEPQ), Advanced Micro Devices (AMD), Chevron (CVX) and Tesla (TSLA).

Company Calendar

Ex-Dividend for 2/3 Dividend
1/23/2025
Dividend Payable
2/03/2025
Last Earnings
2/12/2025
Today
2/22/2025
Next Earnings (Estimated)
5/07/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Sector
Medical
Industry
Drug stores & proprietary stores
Sub-Industry
Drug Retail
CUSIP
12665010
Employees
300,000
Year Founded
1963

Price Target and Rating

Average Stock Price Target
$70.00
High Stock Price Target
$81.00
Low Stock Price Target
$58.00
Potential Upside/Downside
+10.4%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.90
Research Coverage
21 Analysts

Profitability

Net Income
$4.61 billion
Pretax Margin
1.65%

Debt

Sales & Book Value

Annual Sales
$372.81 billion
Cash Flow
$8.86 per share
Book Value
$60.06 per share

Miscellaneous

Outstanding Shares
1,260,800,000
Free Float
1,257,769,000
Market Cap
$79.95 billion
Optionable
Optionable
Beta
0.61

Social Links

Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

This page (NYSE:CVS) was last updated on 2/22/2025 by MarketBeat.com Staff
From Our Partners